White label – Pompe disease - ClinicalTrials.eu

A study to evaluate the effectiveness and safety of ritlecitinib tosilate and loratadine in adults with chronic spontaneous urticaria (hives)

Recruiting

2 1 1
Investigated Diseases:
- Chronic spontaneous urticaria
Investigated Drugs:
- Loratadine
A study to evaluate the use of diroximel fumarate to reduce brain swelling in patients with a stroke caused by bleeding in the brain.

Recruiting

3 1 1
Investigated Diseases:
- Cerebral haemorrhage
Investigated Drugs:
- Diroximel Fumarate
Study of Maridebart Cafraglutide for Adults with Obstructive Sleep Apnea and Overweight or Obesity Who Use Positive Airway Pressure Therapy

Recruiting

3 1
Investigated Diseases:
- Obstructive sleep apnoea syndrome
Investigated Drugs:
- Maridebart Cafraglutide
A study to evaluate the effectiveness and safety of DT-101 in adults with major depressive disorder

Recruiting

2 1
Investigated Diseases:
- Major depression
A study on the use of vancomycin and a drug combination for treating infections in children through continuous antibiotic infusion.

Recruiting

3 1 1 1
Investigated Diseases:
- Bacterial infection
Investigated Drugs:
A study of DS-3790A, rituximab, and epcoritamab in patients with blood cancers

Recruiting

2 1 1 1
Investigated Drugs:
- Epcoritamab
- Rituximab
A study to evaluate the safety and effectiveness of empasiprubart and efgartigimod alfa in patients with generalized myasthenia gravis.

Recruiting

2 1 1
Investigated Diseases:
- Myasthenia gravis
Investigated Drugs:
- Empasiprubart
- Efgartigimod Alfa
+1
A study of islatravir and ulonivirine for adults with HIV who have not received previous treatment

Recruiting

4 1 1
Investigated Diseases:
- HIV infection
Investigated Drugs:
A study to evaluate the safety and effectiveness of nucresiran and vutrisiran in patients with hereditary transthyretin amyloidosis with polyneuropathy

Recruiting

3 1 1 1
Investigated Diseases:
- Polyneuropathy
Investigated Drugs:
- Vutrisiran
+3
A study of IM-101 in adults with generalized myasthenia gravis or ocular myasthenia gravis

Recruiting

1 1 1
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies